{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:01:05Z","timestamp":1793437265634,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jchf.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T13:59:46Z","timestamp":1558965586000},"page":"447-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":335,"title":["Heart\u00a0Failure and Atrial Fibrillation, Like\u00a0Fire\u00a0and\u00a0Fury"],"prefix":"10.1016","volume":"7","author":[{"given":"Matthew A.","family":"Carlisle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"DeVore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2019.03.005_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.mcna.2012.07.007","article-title":"Atrial fibrillation in heart failure","volume":"96","author":"Lardizabal","year":"2012","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jchf.2019.03.005_bib2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1161\/CIRCULATIONAHA.116.026054","article-title":"Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction","volume":"135","author":"Verma","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.03.005_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/cvr\/23.10.882","article-title":"The effect of atrial dilatation on the genesis of atrial arrhythmias","volume":"23","author":"Solti","year":"1989","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2019.03.005_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0002-9149(84)80203-9","article-title":"Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias","volume":"54","author":"Buxton","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0002-9149(65)90454-6","article-title":"Significance of the atrial contribution to ventricular filling","volume":"15","author":"Samet","year":"1965","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033902","article-title":"Clinical impact of atrial fibrillation in patients with pulmonary hypertension","volume":"7","author":"Rottlaender","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2019.03.005_bib7","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1093\/eurheartj\/ehw313","article-title":"Atrial fibrillation: a risk factor or risk marker?","volume":"37","author":"Bunch","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.03.005_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","article-title":"Is atrial fibrillation an inflammatory disorder?","volume":"27","author":"Boos","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.03.005_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/FJC.0b013e31817f9398","article-title":"Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target","volume":"52","author":"Van Wagoner","year":"2008","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jchf.2019.03.005_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1540-8167.2010.01925.x","article-title":"Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)","volume":"22","author":"Negi","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2012.08.056","article-title":"The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis","volume":"167","author":"Bang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.hrthm.2008.04.023","article-title":"Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction","volume":"5","author":"Dandamudi","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jchf.2019.03.005_bib14","first-page":"565","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.03.005_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2016.10.019","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: insights into mechanisms and therapeutics","volume":"176","author":"Patel","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jchf.2019.03.005_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib17","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jacc.2017.09.027","article-title":"Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction","volume":"70","author":"Mogensen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.03.005_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijcard.2016.09.086","article-title":"Atrial fibrillation and heart failure: factors influencing the choice of oral anticoagulant","volume":"227","author":"Brown","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/eurjhf\/hfs005","article-title":"Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project","volume":"14","author":"Banerjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.03.005_bib21","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and\u00a0heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.03.005_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.03.005_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A\u00a0randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib24","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A\u00a0randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2019.03.005_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.03.005_bib27","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2019.03.005_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib30","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2019.03.005_bib31","first-page":"99","article-title":"Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy","volume":"5","author":"Cadrin-Tourigny","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.03.005_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2017.12.001","article-title":"A\u00a0genotype-directed comparative effectiveness trial of bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation\/atrial flutter in patients with heart failure: rationale and design of the GENETIC-AF trial","volume":"199","author":"Piccini","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.03.005_bib33","first-page":"626","article-title":"The clinical benefits and mortality reduction associated with catheter ablation in subjects with atrial fibrillation: a systematic review and meta-analysis","volume":"4","author":"Khan","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jchf.2019.03.005_bib34","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","author":"Turagam","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2019.03.005_bib35","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib36","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.03.005_bib37","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1540-8167.2005.50062.x","article-title":"Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)","volume":"16","author":"Doshi","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2019.03.005_bib39","first-page":"496","article-title":"Treatment of atrial and ventricular arrhythmias through autonomic modulation","volume":"1","author":"Krul","year":"2015","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jchf.2019.03.005_bib40","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jacc.2016.06.036","article-title":"Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study","volume":"68","author":"Driessen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib41","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.jacc.2013.06.053","article-title":"Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"62","author":"Katritsis","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.03.005_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.hrthm.2017.12.001","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Black-Maier","year":"2018","journal-title":"Heart Rhythm"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919301714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919301714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:51:08Z","timestamp":1761972668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177919301714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213177919301714"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2019.03.005","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart\u00a0Failure and Atrial Fibrillation, Like\u00a0Fire\u00a0and\u00a0Fury","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}